Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVAX Vaccine + Lenalidomide in Myeloma
NCT01349569Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jan 2012
- Primary completion
- Oct 2016
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GVAX pancreatic cancer vaccine in multiple myeloma (MM), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jan 2012; status: completed.
02
Drugs
GVAX pancreatic cancer vaccine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01349569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349569.